Showing 1 - 10 of 27
Persistent link: https://www.econbiz.de/10002374960
Persistent link: https://www.econbiz.de/10003715781
Persistent link: https://www.econbiz.de/10005478439
We explore the relation between antitakeover provisions (i.e. managerial entrenchment) and firm performance in innovation. Empirical results indicate that an increase in antitakeover provisions is negatively related to number of patents and number of citations to patents. Thus managers who are...
Persistent link: https://www.econbiz.de/10010744411
Consider migration to a higher income region as a human capital investment in which parents bear migration costs and children share returns. Migrants from a population with heterogeneous intergenerational discount rates will be self-selected on intergenerational altruism. Thus, immigrants may be...
Persistent link: https://www.econbiz.de/10005830168
The subject of the paper is financial valuation of firm's knowledge assets and returns to innovation in the biotechnology industry, where such assets appear to play key role in the commercial success of a product. The biotechnology industry is extremely research-intensive, and successful R&D...
Persistent link: https://www.econbiz.de/10005446482
The U.S. Orphan Drug Act provides R&D incentives to drug-makers that go beyond statutory patent protection. The study explores the act's effect on financial returns to innovation and on the strategy of orphan drug development. Results indicate that the financial return to orphan drug development...
Persistent link: https://www.econbiz.de/10005351079
Recent theoretical literature suggests that the magnitude of the systematic risk premium for a multistage investment project is subject to various forces that may cause the premium to change across stages. To test this hypothesis, I investigate whether Capital Asset Pricing Model (CAPM) beta...
Persistent link: https://www.econbiz.de/10010549218
Persistent link: https://www.econbiz.de/10001454823
Persistent link: https://www.econbiz.de/10001483365